Substance use disorder telehealth treatment in the emergency department/inpatient unit with peer support workers

Peer support model to address substance use disorders treatment engagement in rural communities

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN33100750

Enrollment

110

Registered

2023-10-16

Start date

2022-11-15

Completion date

Unknown

Last updated

2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance use disorder Mental and Behavioural Disorders

Interventions

The purpose of this single-centre project is to evaluate the effectiveness of the Sandoval Regional Medical Center (SRMC) Telehealth Substance Use Disorder Treatment (hereafter referred to as SRMC TH-

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age 18 years old and over 2. English speaking 3. Have an SUD 4. Accessing the ED or medical inpatient services at SRMC

Exclusion criteria

Exclusion criteria: 1. Adults unable to consent 2. Non-English speaking 3. Individuals who are not yet adults (infants, children, teenagers) 4. Prisoners

Design outcomes

Primary

Measure	Time frame
PTSD symptom change as a result of services measured using the Post-traumatic Symptom Checklist – Civilian Version (PCL-C) at baseline and every 60 days thereafter	—

Secondary

Measure	Time frame
The following secondary outcome measures are completed at baseline and every 60 days thereafter: 1. Reasons why they had not previously sought treatment for either their alcohol use or their drug use measured using the Barriers Questionnaire (one for Alcohol and one for Drugs) 2. Craving related to the participant's drug of choice (e.g., cocaine, alcohol, opioids, etc.) measured using the Craving Scale 3. Motivation for change measured using the Motivation to Change Questionnaire (one for Alcohol and one for Drugs) 4. Aspects of recovery related to mental health and well-being measured using the Questionnaire about the Process of Recovery (QPR) 5. Quality of life measured using the RAND 36-Item Short Form Health Survey (SF-36) 6. The frequency of drug and alcohol use within the past 60 days measured using the Addiction Severity Index (ASI) 7. Self-devaluation as a result of substance use measured using the Substance Abuse Self-Stigma Scale (SASSS) 8. Criminal justice involvement in the past 60 days measured using a bespoke Criminal Justice Involvement Survey 9. Service use in the past 6 months measured using a bespoke Service Use Survey 10. Client satisfaction will be measured using the Client Satisfaction Questionnaire (CSQ-8) at follow-up interviews only	—

Measure

Time frame

The following secondary outcome measures are completed at baseline and every 60 days thereafter: 1. Reasons why they had not previously sought treatment for either their alcohol use or their drug use measured using the Barriers Questionnaire (one for Alcohol and one for Drugs) 2. Craving related to the participant's drug of choice (e.g., cocaine, alcohol, opioids, etc.) measured using the Craving Scale 3. Motivation for change measured using the Motivation to Change Questionnaire (one for Alcohol and one for Drugs) 4. Aspects of recovery related to mental health and well-being measured using the Questionnaire about the Process of Recovery (QPR) 5. Quality of life measured using the RAND 36-Item Short Form Health Survey (SF-36) 6. The frequency of drug and alcohol use within the past 60 days measured using the Addiction Severity Index (ASI) 7. Self-devaluation as a result of substance use measured using the Substance Abuse Self-Stigma Scale (SASSS) 8. Criminal justice involvement in the past 60 days measured using a bespoke Criminal Justice Involvement Survey 9. Service use in the past 6 months measured using a bespoke Service Use Survey 10. Client satisfaction will be measured using the Client Satisfaction Questionnaire (CSQ-8) at follow-up interviews only

—

Countries

United States of America

Contacts

Public ContactJustine Saavedra

jlsaavedra@salud.unm.edu+1 5052890637

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026